A US policy perspective on oral preexposure prophylaxis for HIV.

TitleA US policy perspective on oral preexposure prophylaxis for HIV.
Publication TypeJournal Article
Year of Publication2011
AuthorsLeibowitz, AA, Parker KB, Rotheram-Borus MJ
JournalAmerican journal of public health
Volume101
Issue6
Pagination982-5
Date Published2011 Jun
ISSN1541-0048
KeywordsAdministration, Oral, Anti-HIV Agents, Bioethical Issues, Counseling, Health Policy, Health Resources, HIV Infections, Homosexuality, Male, Humans, Male, Randomized Controlled Trials as Topic, United States
Abstract

Orally administered preexposure prophylaxis is an innovative and controversial HIV prevention strategy involving the regular use of antiretroviral medications by uninfected individuals. Antiretroviral medications protect against potential HIV infection by reducing susceptibility to the virus. Recent clinical trial results indicate that preexposure prophylaxis can be safe and efficacious for men who have sexual intercourse with men, yet there remain policy considerations surrounding costs, opportunity costs, and ethical issues that must be addressed before broad implementation in the United States.

Alternate JournalAm J Public Health